Back
Karyopharm Therapeutics Stock Price Chart
Buy
61
KPTI
Karyopharm Therapeutics
Last Price:
1.15
Seasonality Move:
-4.13%
7 Day Trial
ALL ACCESS PASS
$
7
- The current trend is relatively stagnant and KPTI is experiencing slight selling pressure.
Karyopharm Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.1 | Buy |
| 20-day SMA: | 1.09 | Buy |
| 50-day SMA: | 1.26 | Sell |
| 200-day SMA: | 1.14 | Buy |
| 8-day EMA: | 1.12 | Buy |
| 20-day EMA: | 1.13 | Buy |
| 50-day EMA: | 1.18 | Sell |
| 200-day EMA: | 1.43 | Sell |
Karyopharm Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 50.12 | Buy |
| Chaikin Money Flow: | -359886 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.05 - 1.19) | Buy |
| Bollinger Bands (100): | (0.92 - 1.4) | Sell |
Karyopharm Therapeutics Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Karyopharm Therapeutics Stock
Is Karyopharm Therapeutics Stock a Buy?
- Karyopharm Therapeutics share price is 1.15 while KPTI 8-day simple moving average is 1.10, which is a Buy signal.
- The stock price of KPTI is 1.15 while Karyopharm Therapeutics 20-day SMA is 1.09, which makes it a Buy.
- Karyopharm Therapeutics 50-day simple moving average is 1.26 while KPTI share price is 1.15, making it a Sell technically.
- KPTI stock price is 1.15 and Karyopharm Therapeutics 200-day simple moving average is 1.14, creating a Buy signal.
KPTI Technical Analysis vs Fundamental Analysis
Buy
61
Karyopharm Therapeutics (KPTI)
is a Buy
Is Karyopharm Therapeutics a Buy or a Sell?
-
Karyopharm Therapeutics stock is rated a Buy
The current Karyopharm Therapeutics [KPTI] share price is $1.15. The Score for KPTI is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
Karyopharm Therapeutics Stock Info
Market Cap:
135.37M
Price in USD:
1.15
Share Volume:
1.56M
Karyopharm Therapeutics 52-Week Range
52-Week High:
2.67
52-Week Low:
0.62
Buy
61
Karyopharm Therapeutics (KPTI)
is a Buy
Karyopharm Therapeutics Share Price Forecast
-
What is the Karyopharm Therapeutics stock price today?
The Karyopharm Therapeutics stock price is 1.15 USD today. -
Will KPTI stock go up or go down?
Karyopharm Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Karyopharm Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Karyopharm Therapeutics is not overvalued.
Is Karyopharm Therapeutics Stock a Buy?
- Karyopharm Therapeutics share price is 1.15 while KPTI 8-day exponential moving average is 1.12, which is a Buy signal.
- The stock price of KPTI is 1.15 while Karyopharm Therapeutics 20-day EMA is 1.13, which makes it a Buy.
- Karyopharm Therapeutics 50-day exponential moving average is 1.18 while KPTI share price is 1.15, making it a Sell technically.
- KPTI stock price is 1.15 and Karyopharm Therapeutics 200-day simple moving average is 1.43, creating a Sell signal.
Fundamental Analysis of Karyopharm Therapeutics
Is Karyopharm Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.06 per share, a decrease this year of $0.02 per share, and an increase next year of $0.34 per share.
Technical Analysis of Karyopharm Therapeutics
Should I short Karyopharm Therapeutics stock?
- KPTI Moving Average Covergence Divergence (MACD) indicator is -0.03, suggesting Karyopharm Therapeutics is a Sell
- Karyopharm Therapeutics Relative Strength Index (RSI) is 50.12, which suggest Karyopharm Therapeutics is overbought
- The Bollinger Bands (25) for Karyopharm Therapeutics is (1.05 - 1.19), which suggest Karyopharm Therapeutics is a Sell
- The Bollinger Bands (100) for Karyopharm Therapeutics is (0.92 - 1.4), which suggest Karyopharm Therapeutics is a Sell
* Karyopharm Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.